About
Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed coronary CTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRct Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. With over 600,000 patients treated, more than 1,800 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in Mountain View, California, with additional offices in California, Texas, the UK and Japan.
Focus
Lease
Markets
FAQs
Heartflow has financed 1 deal.
Heartflow's most recent deal was on April 09, 2026.
Member since: April 2026
Deals
Transaction Type
Asset Type
State
Sort By
LEASED
Arvind Jain Of Glean Leases 62,000 Square Feet Office Space From John Farquhar Of Heartflow
331 East Evelyn Avenue, Mountain View, CA
CACRE
AJ
Apr 9, 2026